Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo. Try Elite Free for 7 Days

New upgrade: Journal your trades with more detail

Gelteq Limited

Contributing Author

Recent Articles by Gelteq Limited

Jun-17	Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs GELS -7.32% GlobeNewswire
Jun-12	Gelteq Successfully Completes Veterinary Palatability Trials with Kemin, Further Validating Gelteq Technology for Animal Health Applications GELS -35.29% GELS +17.17% GlobeNewswire
Jun-04	Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion GELS +5.78% GlobeNewswire
May-20	Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway GELS +16.66% GlobeNewswire
May-12	Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth GELS GlobeNewswire
Feb-11	Gelteq and Healthy Extracts to Expand Gel-Based Nutrition Technologies with New Strategic Manufacturing & Commercial Partnership GELS GlobeNewswire
Jan-13	Gelteq Announces Positive Preclinical Results Showing Increased Medicinal Cannabinoid Absorption Using Its Oral Gel Delivery Platform GELS +6.44% GlobeNewswire
Dec-16	Gelteq Furthers Asia Presence Through Partnership with Hong Kong Flag Football Program GELS GlobeNewswire
Dec-09	Gelteq Signs Three Year Sales Agreement with Shenzhen Mana Health Management Co. Strengthening Gelteq's Nutritional Product Expansion into China GELS GlobeNewswire
Dec-05	Gelteq Preclinical Study Demonstrates Enhanced Oral Delivery of Oil-Soluble and Poorly Soluble Drugs Using Its Gel-Based Platform GELS GlobeNewswire
Dec-02	Gelteq to Present at Investor Summit Virtual on December 9, 2025 GELS GlobeNewswire
Nov-24	Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform GELS +20.39% GlobeNewswire
Oct-23	Gelteq Announces Commencement of Preclinical Trial Targeting Oil Soluble Drug Market with Novel Delivery Platform GELS +23.01% GlobeNewswire
Oct-09	Gelteq Announces New Product Development Agreement with Melbourne Health for Novel Bowel Polyp Growth Reduction Compound GELS +6.25% GlobeNewswire
Sep-12	Gelteq Technology Powers U.S. Product Launches of its Nutraceutical Products for Partner GELS +6.67% GlobeNewswire
Sep-05	Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy Market GELS +62.50% GlobeNewswire
Jul-17	Gelteq Announces Agreement with IDT Australia to Secure Dedicated New Product Development and Manufacturing Facilities GELS +10.00% GlobeNewswire
Jun-10	Gelteq Expands U.S. Operations with Healthy Extracts Inc. as North American Fulfillment Partner GELS +73.53% GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)